ARCHIVES

In Brief: Richard Fisher Named Fox Chase President and CEO

This article is from The Cancer Letter archive.

Vol. 39 No. 31 | August 2, 2013

Download PDF Visit The Full Archive

Related Articles

Clolar Approved for Pediatric Refractory/Relapsed ALL

January 28, 2005

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma

September 5, 2014

Drug Effectiveness Weakens After Three Years, Study Says

May 27, 2011

Pancreatic Cancer Treatment Shows Postive Early Results

December 30, 2005

In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.

April 2, 1999